Position in ALNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,158,428
-$687,824 QoQ
Shares Held
13,814
-5.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#253
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. ALNY ranks #3 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,398 | $11,622,488 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,444 | $6,512,251 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
13,814 | $4,158,428 | |
| 4 | MRNA |
Moderna, Inc.
|
33,142 | $2,320,934 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
17,163 | $2,278,044 | |
| 6 | CYTK |
Cytokinetics Inc
|
25,572 | $2,178,478 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
5,770 | $2,144,535 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
18,455 | $2,116,234 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,158,428 | 13,814 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,846,252 | 14,647 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,198,965 | 15,589 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,612,416 | 3,536 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,092,845 | 6,418 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,383,196 | 8,826 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,281,330 | 9,695 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,320,712 | 12,074 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,499,686 | 14,402 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,385,401 | 9,270 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,594,828 | 8,332 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,285,214 | 7,257 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,468,046 | 7,729 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,356,166 | 6,770 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,261,508 | 13,724 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,619,694 | 13,088 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,013,459 | 13,805 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,445,267 | 14,975 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,788,912 | 16,446 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,638,746 | 19,272 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,400,740 | 20,061 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,910,349 | 20,613 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,076,779 | 23,673 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,138,553 | 21,556 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,711,192 | 25,057 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $2,279,972 | 20,946 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||